129243-05-6 Usage
General Description
{1,4-bis[(3,4,5-trimethoxyphenyl)carbonyl]piperazin-2-yl}methyl butanoate is a chemical compound with potential pharmaceutical applications. It is a piperazine derivative with two carbonyl groups attached to a piperazine ring, and a methyl butanoate group. The compound contains three trimethoxyphenyl groups, making it a potential candidate for drug development. Piperazine derivatives are known for their psychotropic and anthelmintic properties, and the addition of the trimethoxyphenyl groups may enhance these properties. Additionally, the presence of the methyl butanoate group suggests that the compound may have good solubility and may be suitable for formulation into a drug product. Overall, the chemical structure of {1,4-bis[(3,4,5-trimethoxyphenyl)carbonyl]piperazin-2-yl}methyl butanoate suggests that it may have potential as a pharmaceutical agent.
Check Digit Verification of cas no
The CAS Registry Mumber 129243-05-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,9,2,4 and 3 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 129243-05:
(8*1)+(7*2)+(6*9)+(5*2)+(4*4)+(3*3)+(2*0)+(1*5)=116
116 % 10 = 6
So 129243-05-6 is a valid CAS Registry Number.
129243-05-6Relevant articles and documents
Design and modeling of new platelet-activating factor antagonists. 1. Synthesis and biological activity of 1,4-bis(3',4',5'-trimethoxybenzoyl)-2- [[(substituted carbonyl and carbamoyl)oxy]methyl]piperazines
Lamouri,Heymans,Tavet,Dive,Batt,Blavet,Braquet,Godfroid
, p. 990 - 1000 (2007/10/02)
To further investigate our hypothesis on the structure of the platelet- activating factor (PAF) receptor, 35 compounds derived from 1,4-bis(3',4',5'- trimethoxybenzoyl)piperazine were synthesized and their in vitro antagonistic effect was measured. Substi
